The David H. Koch Institute for Integrative Cancer Research At MIT

About

  • Leadership Council
  • Director's Message
  • Future
  • Scientific Advisory Board
  • FAQs
  • Administration

Faculty

Research

  • KI Approaches to Cancer
  • NCI Research Programs

facilities

  • The Koch Institute
  • Core Facilities

News and Events

  • Grants and Fellowships
  • Cancer Solutions Newsletter
  • Press Kit
  • Summer Symposium

Contact

Support

  • Make a Gift Now
  • Naming Opportunities
  • Bequests and Trusts
  • Corporate Giving
  • Gifts of Stock
  • Gifts of Other Assets
Skip to content

Research

  • KI Approaches to Cancer
  • NCI Research Programs
    • Program 1: Molecular Genetics and Immunology
    • Program 2: Animal Models and Genetics
    • Program 3: Cell and Systems Biology
    • Program 4: Engineering Science and Technology

A Cancer Center Designated by the National Cancer Insitute

Program Four: Engineering Science and Technology

The primary objective of the Engineering Science and Technology Program is to develop innovative technologies that will aid in the understanding, modeling, detection, and treatment of cancer. The following are some of the important research project areas ongoing in EST: implantable microdevices for continuous cancer monitoring, biocompatible quantum dots for imaging, new classes of materials for achieving RNA interference in vivo, formulations for coordinated temporal release of antioangiogenics and cytotoxic drugs, aptamer-targeted drug delivery in prostate cancer, gold nanorods for ablation, and microfluidic devices for measuring the physical properties of individual cancer cells.

Members:

Sangeeta Bhatia and Robert Langer, Program Leaders
Angela Belcher
Michael Cima
Linda Griffith
Paula Hammond
Scott Manalis
Ram Sasisekharan
Alice Ting
Alexander van Oudenaarden